檢索結果 - Susan Lerner

Refine Results
  1. 1
    Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome

    Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome 由 Luis Fayad, Michael J. Keating, James M. Reuben, Susan O’Brien, Bang‐Ning Lee, Susan Lerner, Razelle Kurzrock

    出版 2001
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia

    Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia 由 Marco Montillo, Alessandra Tedeschi, Susan O’Brien, Francesco Di Raimondo, Susan Lerner, Alessandra Ferrajoli, Enrica Morra, Michael J. Keating

    出版 2002
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia

    Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia 由 Paolo Strati, William G. Wierda, Jan A. Burger, Alessandra Ferrajoli, Constantine S. Tam, Susan Lerner, Michael J. Keating, Susan O’Brien

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Professionalism in medical education: The development and validation of a survey instrument to assess attitudes toward professionalism

    Professionalism in medical education: The development and validation of a survey instrument to assess attitudes toward professionalism 由 George F. Blackall, Steven A. Melnick, Glenda Hostetter Shoop, John George, Susan Lerner, Philip K. Wilson, Richard C. Pees, Margaret Kreher

    出版 2007
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Differing effects of cholesterol and taurocholate on steady state hepatic HMG-CoA reductase and cholesterol 7 alpha-hydroxylase activities and mRNA levels in the rat.

    Differing effects of cholesterol and taurocholate on steady state hepatic HMG-CoA reductase and cholesterol 7 alpha-hydroxylase activities and mRNA levels in the rat. 由 Sarah Shefer, L B Nguyen, G Salen, G C Ness, Indu R. Chowdhary, Susan Lerner, A K Batta, G. Stephen Tint

    出版 1992
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Solid Renal Masses in Transplanted Allograft Kidneys: A Closer Look at the Epidemiology and Management

    Solid Renal Masses in Transplanted Allograft Kidneys: A Closer Look at the Epidemiology and Management 由 John J. Griffith, Kamal Adel Amin, Nikhil Waingankar, Susan Lerner, Veronica Delaney, Scott Ames, Ketan K. Badani, Michael Palese, Reza Mehrazin

    出版 2017
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  7. 7
    Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment [see comments]

    Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment [see c... 由 S O'Brien, Hagop M. Kantarjian, Miloslav Beran, Terry Smith, Charles Koller, Elihu H. Estey, L. E. Robertson, Susan Lerner, Michael J. Keating

    出版 1993
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Chemoimmunotherapy may overcome the adverse prognostic significance of 11q deletion in previously untreated patients with chronic lymphocytic leukemia

    Chemoimmunotherapy may overcome the adverse prognostic significance of 11q deletion in previously untreated patients with chronic lymphocytic leukemia 由 Apostolia M. Tsimberidou, Constantine S. Tam, Lynne V. Abruzzo, Susan O’Brien, William G. Wierda, Susan Lerner, Hagop M. Kantarjian, Michael J. Keating

    出版 2008
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia

    Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia 由 Lorenzo Falchi, Candida Vitale, Michael J. Keating, Susan Lerner, X. Wang, Kplola Y. Elhor Gbito, Sara S. Strom, William G. Wierda, Alessandra Ferrajoli

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia

    CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia 由 Sherif Ibrahim, Michael J. Keating, Kim‐Anh Do, Susan O’Brien, Yang O. Huh, Iman Jilani, Susan Lerner, Hagop M. Kantarjian, Maher Albitar

    出版 2001
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype: a study of quantitative flow cytometry and fluorescent <i>in‐situ</i> hybridization in 510 patients

    Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype: a study of quantitative flow cytometry and fluorescent <i>in‐situ</i> hybridization in 510 patien... 由 Constantine S. Tam, Joselle Otero‐Palacios, Lynne V. Abruzzo, Jeffrey L. Jorgensen, Alessandra Ferrajoli, William G. Wierda, Susan Lerner, Susan O’Brien, Michael J. Keating

    出版 2008
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Hodgkin transformation of chronic lymphocytic leukemia

    Hodgkin transformation of chronic lymphocytic leukemia 由 Apostolia M. Tsimberidou, Susan O’Brien, Hagop M. Kantarjian, Charles Koller, Fredrick B. Hagemeister, Luis Fayad, Susan Lerner, Carlos E. Bueso‐Ramos, Michael J. Keating

    出版 2006
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab – incidence and predictors

    Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab – incidence and predictors 由 Gautam Borthakur, Susan O’Brien, William G. Wierda, Deborah A. Thomas, Jorge E. Cortés, Francis J. Giles, Hagop M. Kantarjian, Susan Lerner, Michael J. Keating

    出版 2007
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Phase II study of alemtuzumab in chronic lymphoproliferative disorders

    Phase II study of alemtuzumab in chronic lymphoproliferative disorders 由 Alessandra Ferrajoli, Susan O’Brien, Jorge E. Cortés, Francis J. Giles, Deborah A. Thomas, Stefan Faderl, Razelle Kurzrock, Susan Lerner, Dimitrios P. Kontoyiannis, Michael J. Keating

    出版 2003
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Technical challenges of hepatic venous outflow reconstruction in right lobe adult living donor liver transplantation

    Technical challenges of hepatic venous outflow reconstruction in right lobe adult living donor liver transplantation 由 Rafik M. Ghobrial, Chung Bao Hsieh, Susan Lerner, Sharon Winters, Nicholas Nissen, Sherfield Dawson, Farin Amersi, Pauline Chen, Douglas G. Farmer, Hasan Yersiz, Ronald W. Busuttil

    出版 2001
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia

    Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia 由 Constantine S. Tam, Susan O’Brien, William G. Wierda, Hagop M. Kantarjian, Sijin Wen, Kim‐Anh Do, Deborah A. Thomas, Jorge E. Cortés, Susan Lerner, Michael J. Keating

    出版 2008
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Addition of Plasmapheresis Decreases the Incidence of Acute Antibody-Mediated Rejection in Sensitized Patients with Strong Donor-Specific Antibodies

    Addition of Plasmapheresis Decreases the Incidence of Acute Antibody-Mediated Rejection in Sensitized Patients with Strong Donor-Specific Antibodies 由 Enver Akalin, Rajani Dinavahi, Rex Friedlander, Scott Ames, Graciela de Boccardo, Vinita Sehgal, Bernd SchroCombining Diaeresisppel, Madhu Bhaskaran, Susan Lerner, Marileno Fotino, Barbara Murphy, Jonathan S. Bromberg

    出版 2008
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia

    Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia 由 Xavier C. Badoux, Michael J. Keating, Xuemei Wang, Susan O’Brien, Alessandra Ferrajoli, Stefan Faderl, Jan A. Burger, Charles Koller, Susan Lerner, Hagop M. Kantarjian, William G. Wierda

    出版 2011
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL

    Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL 由 Xavier C. Badoux, Michael J. Keating, Xuemei Wang, Susan O’Brien, Alessandra Ferrajoli, Stefan Faderl, Jan A. Burger, Charles Koller, Susan Lerner, Hagop M. Kantarjian, William G. Wierda

    出版 2011
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone

    Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone 由 Apostolia M. Tsimberidou, Daniel Catovsky, Ellen Schlette, Susan O’Brien, William G. Wierda, Hagop M. Kantarjian, Guillermo Garcia‐Manero, Sijin Wen, Kim‐Anh Do, Susan Lerner, Michael J. Keating

    出版 2006
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: